bioRxiv · 10.1101/2022.03.24.485696
A microbiota membrane disrupter disseminates to the pancreas and increases β-cell mass
Abstract
Microbiome dysbiosis is a feature of diabetes, but how microbial products influence insulin production is poorly understood. Here we report the mechanism of BefA, a microbiome-derived protein that increases proliferation of insulin-producing {beta}-cells during pancreatic development in gnotobiotic zebrafish and mice. BefA disseminates systemically via multiple anatomic routes to act directly on pancreatic islets. We report the structure of BefA, containing a lipid-binding SYLF domain, and demonstrate that it permeabilizes synthetic liposomes and bacterial membranes. A BefA mutant impaired in membrane disruption fails to expand {beta}-cells whereas the pore-forming host defense protein, Reg3, stimulates {beta}-cell proliferation. Our work demonstrates that membrane permeabilization by microbiome-derived and host defense proteins is necessary and sufficient for {beta}-cell expansion during pancreas development, thereby connecting microbiome composition with diabetes risk.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Hill, J. H., Massaquoi, M. S., Sweeney, E. G., Wall, E. S., Bell, R., Kallio, K., Derrick, D., Murtaugh, L. C., Parthasarathy, R., Remington, S. J., Round, J. L., Guillemin, K.. 2022-03-24. A microbiota membrane disrupter disseminates to the pancreas and increases β-cell mass. https://doi.org/10.1101/2022.03.24.485696
Cite the original work for its findings. Save a collection to share your selection of sources.